BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06525220-completion@plaintrial.com
DTSTAMP:20261028T062355Z
DTSTART;VALUE=DATE:203007
SUMMARY:A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pemb
 rolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1) 
 — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06525220
URL:https://plaintrial.com/trial/NCT06525220
END:VEVENT
END:VCALENDAR